Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Tissue Barriers
ISSN 2168-8370 · Taylor & Francis
Tissue Barriers: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.1 (journal website); JCR Q2 (journal website); hybrid open access; APC charged, amount not published; median 108 days to acceptance (75 articles, last 24 months); acceptance rate 38% (journal website); 44 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Tissue Barriers is published by Taylor & Francis and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Barrier Structure and Function Studies, Gut microbiota and health and Connexins and lens biology, together about 41.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Tissue Barriers is the first international interdisciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the diverse and complex tissue barriers that occur across tissue and cell types, including the molecular composition and dynamics of polarized cell junctions and cell-cell interactions during normal homeostasis, injury and disease state. Tissue barrier formation in regenerative medicine and restoration of tissue and organ function is also of interest. Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome. Tissue Barriers objectives: Promote interdisciplinary awareness and collaboration between researchers working with epithelial, epidermal and endothelial barriers and to build a broad and cohesive worldwide community of scientists interesting in this exciting field. Comprehend the enormous complexity of tissue barriers and map cross-talks and interactions between their different cellular and non-cellular components. Highlight the roles of tissue barrier dysfunctions in human diseases. Promote understanding and strategies for restoration of tissue barrier formation and function in regenerative medicine. Accelerate a search for pharmacological enhancers of tissue barriers as potential therapeutic agents. Understand and optimize drug delivery across epithelial and endothelial barriers. Publication Office: Taylor & Francis Group, 530 Walnut Street | Suite 850, Philadelphia, PA 19106
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Kursad TurksenPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Barrier Structure and Function StudiesNeuroscience29.1%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology6.6%
- Connexins and lens biologyBiochemistry, Genetics and Molecular Biology5.7%
- Wnt/β-catenin signaling in development and cancerBiochemistry, Genetics and Molecular Biology5.2%
- Cell Adhesion Molecules ResearchMedicine4.6%
- Hippo pathway signaling and YAP/TAZBiochemistry, Genetics and Molecular Biology4.1%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4.1%
- Drug Transport and Resistance MechanismsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 5Publisher website ·
- CiteScore 2026-06
- 8.6LetPub ·
- CiteScore (publisher) 2025
- 8.6Publisher website ·
- SJR 2026-06
- 1.43LetPub ·
- SJR (publisher) 2025
- 1.43Publisher website ·
- SNIP 2026-06
- 1.4LetPub ·
- SNIP (publisher) 2025
- 1.4Publisher website ·
- h-index
- 70OpenAlex ·
- i10-index
- 265OpenAlex ·
- 2-year mean citedness
- 3.82OpenAlex ·
- Self-citation rate
- 3.2%LetPub ·
- Share of gold OA articles
- 13.98%LetPub ·
Volume
- Articles per year
- 37LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
- Downloads per year (publisher)
- 170,000Publisher website ·
Articles by year OpenAlex count · 431 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 13 | 11 |
| 2025 | 44 | 44 | 177 |
| 2024 | 41 | 40 | 232 |
| 2023 | 24 | 24 | 270 |
| 2022 | 26 | 26 | 580 |
| 2021 | 45 | 45 | 1,175 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
108 daysMedian, submission to acceptance · P25–P75 72 days – 141 days
- Acceptance to online
- median 13 days (75 articles)
- Submission to online
- median 130 days
- Sample
- 75 articles with submission and acceptance dates (78 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 38%Publisher website ·
- Submission to first decision
- 27 daysPublisher website ·
- First decision after review
- 44 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7
- hypothesisTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- meeting reportsTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- original research papersTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- perspectives and commentariesTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- reviewsTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- short communicationsTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
- technical papersTissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and …Length not stated
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Hybrid open access journal, part of Taylor & Francis Open Select publishing program. Model summary
Tissue Barriers is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readers…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 2168-8370
- Latest issue on the website
- Volume 14, Issue 3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Tissue Barriers
What CAS zone is Tissue Barriers in?
In the 2025 upgraded edition of the CAS Journal Ranking, Tissue Barriers is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Tissue Barriers?
The journal's website gives an impact factor of 3.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 8.6, h-index 70.
How long does peer review take at Tissue Barriers?
Based on the dates recorded on 75 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 72–141 days); the journal's website gives an acceptance rate of 38%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Tissue Barriers in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Tissue Barriers?
According to LetPub and DOAJ records, Tissue Barriers is indexed in ESCI and Scopus. The journal's website also lists Web of Science, MEDLINE and PMC; that list has not been checked against each database.
Is Tissue Barriers open access, and what is the APC?
Tissue Barriers is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .